UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 111

Sortiert nach

Cardiovascular disease after Hodgkin lymphoma treatment: 40-year disease risk

JAMA internal medicine, 2015-06, Vol.175 (6), p.1007

2015

Link zum Volltext

Verfügbarkeit prüfen

MiR423-5p As a Circulating Biomarker for Heart Failure

Circulation research, 2010-04, Vol.106 (6), p.1035-1039

2010

Link zum Volltext

Verfügbarkeit prüfen

High Risk of Symptomatic Cardiac Events in Childhood Cancer Survivors

Journal of clinical oncology, 2012-05, Vol.30 (13), p.1429-1437

2012

Link zum Volltext

Verfügbarkeit prüfen

Incidence of capecitabine-related cardiotoxicity in different treatment schedules of metastatic colorectal cancer: A retrospective analysis of the CAIRO studies of the Dutch Colorectal Cancer Group

European journal of cancer (1990), 2017-05, Vol.76, p.93-99

2017

Link zum Volltext

Verfügbarkeit prüfen

Unravelling the gut hypothesis of heart failure with gut microbiota‐derived metabolites

European journal of heart failure, 2024-02, Vol.26 (2), p.242-244

Kok, Wouter E.

2024

Link zum Volltext

Verfügbarkeit prüfen

Clinical heart failure in a cohort of children treated with anthracyclines: A long-term follow-up study

European journal of cancer (1990), 2006-12, Vol.42 (18), p.3191-3198

2006

Link zum Volltext

Verfügbarkeit prüfen

Editorial commentary: Biomarkers in heart failure, between scientific scrutiny and exploration

Trends in cardiovascular medicine, 2017-02, Vol.27 (2), p.134-135

Kok, Wouter E., MD, PhD

2017

Link zum Volltext

Verfügbarkeit prüfen

Asymptomatic systolic dysfunction on contemporary echocardiography in anthracycline-treated long-term childhood cancer survivors: a systematic review

Journal of cancer survivorship, 2022-04, Vol.16 (2), p.338-352

2022

Link zum Volltext

Verfügbarkeit prüfen

Serum potassium decline during hospitalization for acute decompensated heart failure is a predictor of 6-month mortality, independent of N-terminal pro–B-type natriuretic peptide levels: An individual patient data analysis

The American heart journal, 2015-09, Vol.170 (3), p.531-542.e1

2015

Link zum Volltext

Verfügbarkeit prüfen

Competing Risk of Cardiac Status and Renal Function During Hospitalization for Acute Decompensated Heart Failure

JACC. Heart failure, 2015-10, Vol.3 (10), p.751-761

2015

Link zum Volltext

Verfügbarkeit prüfen

Extracellular matrix remodeling in animal models of anthracycline-induced cardiomyopathy: a meta-analysis

Journal of molecular medicine (Berlin, Germany), 2021-09, Vol.99 (9), p.1195-1207

2021

Link zum Volltext

Verfügbarkeit prüfen

Rationale and design of PRIMA II: A multicenter, randomized clinical trial to study the impact of in-hospital guidance for acute decompensated heart failure treatment by a predefined NT-PRoBNP target on the reduction of readmIssion and Mortality rAtes

The American heart journal, 2014-07, Vol.168 (1), p.30-36

2014

Link zum Volltext

Verfügbarkeit prüfen

Case series of patients treated with the oral fluoropyrimidine S-1 after capecitabine-induced coronary artery vasospasm

European journal of cancer (1990), 2017-08, Vol.81, p.130-134

2017

Link zum Volltext

Verfügbarkeit prüfen

Electrocardiographic abnormalities in childhood cancer survivors treated with cardiotoxic therapy: a systematic review

Pediatric blood & cancer, 2022-08, Vol.69 (8), p.e29720-n/a

2022

Link zum Volltext

Verfügbarkeit prüfen

Response to: Letter to the editor regarding the manuscript “Rationale and design of PRIMA II: A multicenter, randomized clinical trial to study the impact of in-hospital guidance for acute decompensated heart failure treatment by a predefined NT-ProBNP target on the reduction of readmission and Mortality rAtes”

The American heart journal, 2015-04, Vol.169 (4), p.e5-e5

2015

Link zum Volltext

Verfügbarkeit prüfen

N-Terminal Pro–B-Type Natriuretic Peptide (NT-proBNP) Measurements Until a 30% Reduction Is Attained During Acute Decompensated Heart Failure Admissions and Comparison With Discharge NT-proBNP Levels: Implications for In-Hospital Guidance of Treatment

Journal of cardiac failure, 2015-11, Vol.21 (11), p.930-934

2015

Link zum Volltext

Verfügbarkeit prüfen

External Validation of the ELAN-HF Score, Predicting 6-Month All-Cause Mortality in Patients Hospitalized for Acute Decompensated Heart Failure

Journal of the American Heart Association, 2019-07, Vol.8 (14), p.e010309-e010309

2019

Link zum Volltext

Verfügbarkeit prüfen

Multimodality Screening For (Peri)Myocarditis In Newly Diagnosed Idiopathic Inflammatory Myopathies: A Cross-Sectional Study

Journal of neuromuscular diseases, 2023-01, Vol.10 (2), p.185-197

2023

Link zum Volltext

Verfügbarkeit prüfen

Nutrition before, during, and after surgery increases the arginine:asymmetric dimethylarginine ratio and relates to improved myocardial glucose metabolism: a randomized controlled trial

The American journal of clinical nutrition, 2014-06, Vol.99 (6), p.1440-1449

2014

Link zum Volltext

Verfügbarkeit prüfen

Valvular Abnormalities Detected by Echocardiography in 5-Year Survivors of Childhood Cancer: A Long-Term Follow-Up Study

International journal of radiation oncology, biology, physics, 2015, Vol.91 (1), p.213-222

2015

Link zum Volltext

Verfügbarkeit prüfen

NT-proBNP-Guided Therapy in Acute Decompensated Heart Failure: The PRIMA II Randomized Controlled Trial

Circulation (New York, N.Y.), 2018-04, Vol.137 (16), p.1671-1683

2018

Link zum Volltext

Verfügbarkeit prüfen

Systolic heart failure: a prothrombotic state

Seminars in thrombosis and hemostasis, 2009-07, Vol.35 (5), p.497

2009

Link zum Volltext

Verfügbarkeit prüfen

A novel discharge risk model for patients hospitalised for acute decompensated heart failure incorporating N-terminal pro-B-type natriuretic peptide levels: a European coLlaboration on Acute decompeNsated Heart Failure: ÉLAN-HF Score

Heart (British Cardiac Society), 2014-01, Vol.100 (2), p.115-125

2014

Link zum Volltext

Verfügbarkeit prüfen

Feasibility of CD19 CAR T-cell therapy in patients with cardiac lymphoma

Leukemia & lymphoma, 2024-03, Vol.65 (3), p.399-402

2024

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 111

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(105)
Mit Volltextzugriff
(102)

Publikationsform

Artikel
(110)
Buchkapitel
(1)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Cardiovascular disease after Hodgkin lymphoma treatment: 40-year disease risk

MiR423-5p As a Circulating Biomarker for Heart Failure

High Risk of Symptomatic Cardiac Events in Childhood Cancer Survivors

Incidence of capecitabine-related cardiotoxicity in different treatment schedules of metastatic colorectal cancer: A retrospective analysis of the CAIRO studies of the Dutch Colorectal Cancer Group

Unravelling the gut hypothesis of heart failure with gut microbiota‐derived metabolites

Clinical heart failure in a cohort of children treated with anthracyclines: A long-term follow-up study

Editorial commentary: Biomarkers in heart failure, between scientific scrutiny and exploration

Asymptomatic systolic dysfunction on contemporary echocardiography in anthracycline-treated long-term childhood cancer survivors: a systematic review

Serum potassium decline during hospitalization for acute decompensated heart failure is a predictor of 6-month mortality, independent of N-terminal pro–B-type natriuretic peptide levels: An individual patient data analysis

Competing Risk of Cardiac Status and Renal Function During Hospitalization for Acute Decompensated Heart Failure

Extracellular matrix remodeling in animal models of anthracycline-induced cardiomyopathy: a meta-analysis

Rationale and design of PRIMA II: A multicenter, randomized clinical trial to study the impact of in-hospital guidance for acute decompensated heart failure treatment by a predefined NT-PRoBNP target on the reduction of readmIssion and Mortality rAtes

Case series of patients treated with the oral fluoropyrimidine S-1 after capecitabine-induced coronary artery vasospasm

Electrocardiographic abnormalities in childhood cancer survivors treated with cardiotoxic therapy: a systematic review

N-Terminal Pro–B-Type Natriuretic Peptide (NT-proBNP) Measurements Until a 30% Reduction Is Attained During Acute Decompensated Heart Failure Admissions and Comparison With Discharge NT-proBNP Levels: Implications for In-Hospital Guidance of Treatment

External Validation of the ELAN-HF Score, Predicting 6-Month All-Cause Mortality in Patients Hospitalized for Acute Decompensated Heart Failure

Multimodality Screening For (Peri)Myocarditis In Newly Diagnosed Idiopathic Inflammatory Myopathies: A Cross-Sectional Study

Nutrition before, during, and after surgery increases the arginine:asymmetric dimethylarginine ratio and relates to improved myocardial glucose metabolism: a randomized controlled trial

Valvular Abnormalities Detected by Echocardiography in 5-Year Survivors of Childhood Cancer: A Long-Term Follow-Up Study

NT-proBNP-Guided Therapy in Acute Decompensated Heart Failure: The PRIMA II Randomized Controlled Trial

Systolic heart failure: a prothrombotic state

A novel discharge risk model for patients hospitalised for acute decompensated heart failure incorporating N-terminal pro-B-type natriuretic peptide levels: a European coLlaboration on Acute decompeNsated Heart Failure: ÉLAN-HF Score

Feasibility of CD19 CAR T-cell therapy in patients with cardiac lymphoma

Presence and utility of electrocardiographic abnormalities in long-term childhood cancer survivors

Suchergebnisse filtern